Daseke Inc (DSKE) Director Mark Sinclair Acquires 10,000 Shares

Share on StockTwits

Daseke Inc (NASDAQ:DSKE) Director Mark Sinclair bought 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 4th. The stock was purchased at an average price of $3.77 per share, with a total value of $37,700.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Daseke stock traded down $0.21 during mid-day trading on Friday, hitting $3.25. 1,034,315 shares of the company were exchanged, compared to its average volume of 463,600. The company has a debt-to-equity ratio of 1.51, a current ratio of 1.81 and a quick ratio of 1.81. Daseke Inc has a 1-year low of $3.24 and a 1-year high of $14.52. The firm has a market capitalization of $223.01 million, a P/E ratio of -5.42 and a beta of 1.29.

Daseke (NASDAQ:DSKE) last released its quarterly earnings data on Tuesday, November 6th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.03). Daseke had a return on equity of 2.25% and a net margin of 3.77%. The company had revenue of $461.59 million for the quarter, compared to analyst estimates of $430.29 million. During the same quarter in the prior year, the company earned ($0.03) earnings per share. The business’s revenue was up 99.5% compared to the same quarter last year. On average, equities research analysts predict that Daseke Inc will post 0.07 EPS for the current fiscal year.

Several research firms have issued reports on DSKE. Cowen reiterated a “buy” rating and set a $15.00 price objective on shares of Daseke in a research note on Friday, August 10th. BidaskClub lowered Daseke from a “hold” rating to a “sell” rating in a research note on Tuesday, September 25th. Finally, Craig Hallum lowered Daseke from a “buy” rating to a “hold” rating in a research note on Tuesday, November 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $14.88.

A number of institutional investors have recently added to or reduced their stakes in DSKE. Virtu Financial LLC acquired a new position in Daseke during the third quarter worth $127,000. Millennium Management LLC bought a new stake in shares of Daseke during the first quarter worth $148,000. Arcus Capital Partners LLC bought a new stake in shares of Daseke during the third quarter worth $164,000. Los Angeles Capital Management & Equity Research Inc. bought a new stake in shares of Daseke during the second quarter worth $168,000. Finally, PEAK6 Investments LLC bought a new stake in shares of Daseke during the third quarter worth $168,000. Hedge funds and other institutional investors own 36.15% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Daseke Inc (DSKE) Director Mark Sinclair Acquires 10,000 Shares” was originally reported by BBNS and is the sole property of of BBNS. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://baseballnewssource.com/2018/12/08/daseke-inc-dske-director-mark-sinclair-acquires-10000-shares/3065145.html.

About Daseke

Daseke, Inc provides transportation and logistics solutions with a focus on flatbed and specialized freight in North America. It operates through Flatbed Solutions and Specialized Solutions segments. The company transports heavy haul freight, defense and commercial arms, ammunition and explosives, radioactive cargo and hazardous materials, and commercial sheet glass, as well as offers 10-wheel drive-away services.

Featured Article: What is the quiet period?

Receive News & Ratings for Daseke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daseke and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.